Where can I buy Brigatinib? How to buy?

Brigatinib/Brigatinib (Brigatinib) is mainly used to treat ALK (anaplastic lymphoma kinase) fusion-positive NSCLC patients. ALK is a tyrosine kinase that has abnormal fusion in some NSCLC patients, leading to the development of ALK fusion-positive tumors. Brigatinib/Brigatinib selectively inhibits the activity of ALK fusion protein and blocks abnormal signaling pathways, thereby inhibiting the growth and spread of tumor cells.

It needs to be emphasized that the use of Brigatinib/Brigatinib should be done under the guidance of a doctor and needs to be confirmed by ALK fusion-positive gene testing. Only after the patient's ALK fusion-positive status is clarified can it be determined whether the patient is suitable for brigatinib/brigatinib treatment.

As a targeted drug, Brigatinib/Brigatinib has shown significant efficacy in the treatment of ALKfusion-positive NSCLC. However, each patient's situation is unique and treatment options should be individualized based on the patient's specific circumstances. It is important to work closely with your doctor, follow your treatment plan and have regular follow-up visits.

Brigatinib/Brigatinib has been launched in China and has been included in medical insurance. Since it has just been approved for marketing, patients may not be able to buy it in domestic pharmacies. If you need to purchase it in China, please consult the local pharmacy. However, the price is quite high, more than 10,000 yuan. ForeignBrigatinib/BrigatinibThey are mainly generic drugs, mainly from Bangladesh and Laos. The price of the international version of the Bangladeshi generic drug Yaobin is about 2000 yuan, and the specification is 90mg*30 tablets; the price of the Lao version of the generic drug is about 600 and the specification is smaller. And the ingredients of domestic original drugs and foreign generic drugs are basically the same.